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What is the prognostic value 
of stress echocardiography for
patients with atypical chest pain?
Patients with atypical chest pain and 
no history of cardiovascular events 
(coronary artery disease, unstable angina,
or history of percutaneous transthoracic
coronary angioplasty [PTCA]) and a 
negative stress echocardiography test are
unlikely to experience a cardiovascular
event in the next 1 to 4 years. However,
the positive predictive value of the test in
this population is low, indicating that a 
positive stress echocardiography is less
useful for prognostic purposes (strength 
of recommendation: B, based on multiple
cohort studies).
E V I D E N C E - B A S E D A N SW E R
Using stress echocardiography 
reduces need for diagnostic cardiac
catheterization for atypical chest pain
Patients presenting to emergency and
urgent care departments with atypical chest
pain are a dilemma whenever their ECG
and biomarkers are nondiagnostic. Graded
exercise stress testing to further define risk
is not effective in many patient populations:
including some women, patients with 
mobility problems, and patients with 
underlying conduction issues such as 
pre-excitation syndromes, left bundle
branch blocks, and ventricular pacemakers.
Stress echocardiography is a reasonable
alternative for such patients. While 
physicians may take a negative test at face
value in this clinical setting, a positive test 
is not diagnostic and will often necessitate
further workup. Using stress echo-
cardiography therefore reduces but does
not eliminate the need for diagnostic 
cardiac catheterization for atypical chest
pain.
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z Evidence summary
A prospective cohort study1 evaluated
dobutamine or dipyridamole pharmaco-
logic stress echocardiography among 904
primary care patients with either typical
or atypical chest pain. Patients were
enrolled into the study if they had normal
resting wall motion, sinus rhythm, and
had no history of coronary artery disease,
unstable angina, or PTCA. Patients 
(average age 61 years, 42% men) were 
followed for an average of 44 months for
primary cardiovascular endpoints (fatal or
nonfatal myocardial infarction [MI],
unstable angina, PTCA, or cardiac death).
A negative or positive stress echocardio-
graphy is defined as the absence or pres-
ence of abnormal cardiac wall motion on
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either exercise or pharmacologic stress
echocardiography. Eighteen percent of
patients had a positive pharmacologic
stress echocardiography. Over the length
of the study, 81 of 904 patients (9%) 
suffered a cardiovascular event. Patients
with a negative pharmacologic stress
echocardiography had a mean annual
probability of a cardiovascular event of
0.8% vs 8.5% with a positive pharmaco-
logic stress echocardiography (P<.0001).
The 4-year infarct-free negative predictive
value (NPV) of pharmacologic stress
echocardiography was 97%, and the pos-
itive predictive value (PPV) was 70%. 
A similar prospective cohort study2
evaluated 105 patients (50% men) with
atypical chest pain in an emergency
department setting with either exercise or
dobutamine/atropine stress echocardio-
graphy. The average patient age was 55
years and follow-up was 2.8 years.
Patients were clinically stable, had normal
or nondiagnostic electrocardiogram
(ECG), normal cardiac enzymes, normal
left ventricular function, and no history of
coronary artery disease or unstable angi-
na. Cardiovascular endpoints included
fatal or nonfatal MI, unstable angina,
PTCA, or cardiac death. A total of 7
patients (7%) suffered a cardiovascular
event during the follow-up period.
Positive stress echocardiography results
occurred for 9% of patients. The NPV
was 99% and the PPV was 75%. 
Three other cohort studies3–5 evaluated
exercise or dobutamine/atropine stress
echocardiography for a total of 615
patients (48%–67% men, average age
56–58 years) presenting to an emergency
department with classical cardiac or atypi-
cal chest pain. Patients had normal or non-
diagnostic ECG, negative cardiac enzymes,
and either no history of coronary artery
disease3,4 or known coronary artery disease
of unknown significance.5 A positive stress
echocardiography was obtained for 4.8%
to 42% of patients in the cohorts. During
6 months of follow-up, cardiovascular
events occurred in 4 of 145 patients (3%),3
22 of 227 patients (6%),4 and in 11 of 80
patients (14%).5 At 6-month follow-up,
exercise stress echocardiography had a
NPV of 99.3% and a PPV of 43%.3
Dobutamine/atropine stress echocardio-
graphy had a NPV of 95% to 96% and a
PPV of 25% to 31%.4,5
One retrospective review6 evaluated
exercise and dobutamine/atropine stress
echocardiography and stress ECG for 661
low-risk outpatients (48% men, average
age 58 years) with atypical chest pain. All
patients had normal left ventricular func-
tion and no history of coronary artery
disease and were followed for an average
of 23 months. A positive stress echocar-
diography test occurred among 16% of
the patient population. 
During follow-up, 41 of 661 patients
(6%) suffered a cardiovascular event. For
either exercise or dobutamine/atropine
stress echocardiography, the NPV was
99% at 12 months and 96% at 30
months. Patients with a positive stress
echocardiography test and a negative
stress ECG had a 66% event-free survival
rate. Event-free survival rate for patients
with a negative stress echocardiography
and a positive or negative stress ECG was
97% and 96%, respectively.
Recommendations from others
The American College of Cardiology7
gives a Class I recommendation (tests for
which there is evidence or general agree-
ment that a given procedure or treatment
is useful and effective) for standard
echocardiogram for evaluation of chest
pain for patients with suspected acute
myocardial ischemia (when baseline ECG
and other laboratory markers are nondi-
agnostic and when the study can be
obtained during pain or within minutes
after its abatement).
It gives a Class IIa recommendation
(tests for which there is conflicting evi-
dence or divergence of opinion, but favor-
ing usefulness) to stress echocardiography
for the detection of myocardial ischemia
for women with an intermediate pretest
likelihood of coronary artery disease. It
also gives a Class IIa recommendation to
Stress 
echocardiography
reduces but does
not eliminate 
the need for 
diagnostic cardiac
catheterization
FAST TRACK
stress echocardiography for determining
the prognosis of myocardial ischemia
among patients for whom ECG assess-
ment is less reliable. This group compris-
es patients with the following ECG
abnormalities: pre-excitation syndrome
(such as Wolff-Parkinson-White), elec-
tronically paced ventricular rhythm, more
than 1 mm of ST depression at rest, and
complete left bundle branch block.
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